GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ulisse Biomed SpA (MIL:UBM) » Definitions » Other Stockholders Equity

Ulisse Biomed SpA (MIL:UBM) Other Stockholders Equity : €0.68 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ulisse Biomed SpA Other Stockholders Equity?

Ulisse Biomed SpA's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €0.68 Mil.

Ulisse Biomed SpA's quarterly Other Stockholders Equity increased from Dec. 2023 (€0.68 Mil) to Jun. 2024 (€0.68 Mil) but then declined from Jun. 2024 (€0.68 Mil) to Dec. 2024 (€0.68 Mil).

Ulisse Biomed SpA's annual Other Stockholders Equity declined from Dec. 2022 (€0.68 Mil) to Dec. 2023 (€0.68 Mil) and declined from Dec. 2023 (€0.68 Mil) to Dec. 2024 (€0.68 Mil).


Ulisse Biomed SpA Other Stockholders Equity Historical Data

The historical data trend for Ulisse Biomed SpA's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ulisse Biomed SpA Other Stockholders Equity Chart

Ulisse Biomed SpA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial 0.67 0.68 0.68 0.68 0.68

Ulisse Biomed SpA Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.68 0.68 0.68 0.68 0.68

Ulisse Biomed SpA Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Ulisse Biomed SpA Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Ulisse Biomed SpA's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Ulisse Biomed SpA Business Description

Traded in Other Exchanges
N/A
Address
Area Science Park - SS14 km.163, 5, Basovizza, ITA, 34149
Ulisse Biomed SpA is a healthcare biotech company. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions. The company has three technology platforms, namely, Sagitta for molecular diagnostics, NanoHybrid for theranostics and diagnostics, and Aptavir for therapeutics.

Ulisse Biomed SpA Headlines

No Headlines